Holen Sie sich die Stockscreener-App
46.70
2.01%
-0.96
Handel nachbörslich:
47.02
0.32
+0.69%
Crispr Therapeutics Ag Aktie (CRSP) Neueste Nachrichten
CRISPR Therapeutics AG (CRSP) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Traders Buy High Volume of Call Options on CRISPR Therapeutics (NASDAQ:CRSP) - MarketBeat
CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It - MSN
From Now to 2032: Unpacking the Genome Editing Market's - openPR.com
CRISPR Therapeutics’ SWOT analysis: gene editing pioneer’s stock faces pivotal year - Investing.com
Gene-Editing Stocks Gain on LLY-VERV Deal Announcement - Yahoo
Citizens JMP reiterates CRISPR Therapeutics stock rating on in-vivo progress - Investing.com
SG Americas Securities LLC Grows Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
CRISPR Therapeutics (NASDAQ:CRSP) Shares Gap UpShould You Buy? - MarketBeat
Editas Medicine Is Great. Here's Why You Shouldn't Buy It. - The Motley Fool
25,341 Shares in CRISPR Therapeutics AG (NASDAQ:CRSP) Purchased by Avanza Fonder AB - MarketBeat
Can a $10,000 Investment in CRISPR Therapeutics Turn Into $1 Million? - 24/7 Wall St.
Millennium Management LLC Trims Stock Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
Equities Analysts Set Expectations for CRSP FY2026 Earnings - MarketBeat
Crispr extends gains for the seventh consecutive trading day - MSN
Crispr Therapeutics: Betting On A One-Shot Future (NASDAQ:CRSP) - Seeking Alpha
Trend Tracker for (CRSP) - news.stocktradersdaily.com
CRISPR Therapeutics (NASDAQ:CRSP) Trading Up 6%Here's What Happened - MarketBeat
Crispr Therapeutics AG: Stock Soars Amid Bullish Trends - MSN
CRISPR Therapeutics Gains 14% in a Month: How to Play the Stock? - Yahoo Finance
Crispr Therapeutics: Early-Stage Research Updates Show Promise (NASDAQ:CRSP) - Seeking Alpha
Cantor Fitzgerald Weighs in on CRSP FY2026 Earnings - Defense World
CRISPR Therapeutics AG (CRSP) Rises Higher Than Market: Key Facts - Yahoo Finance
Crispr Therapeutics (CRSP) Rallies Amid FDA Fast-Tracking News - GuruFocus
Crispr extends gains for the seventh consecutive trading day (CRSP:NASDAQ) - Seeking Alpha
CRISPR Therapeutics AG shareholders approve key proposals By Investing.com - Investing.com South Africa
CRISPR Therapeutics AG Shareholders Approve Key Proposals - TipRanks
CRISPR Therapeutics AG shareholders approve key proposals - Investing.com
Cathie Wood Just Flagged The Start Of A Biotech Revolution: These 2 Stocks With 10x Potential Are Leading It - Benzinga
Wealth Enhancement Advisory Services LLC Has $1.08 Million Stake in CRISPR Therapeutics AG (NASDAQ:CRSP) - Defense World
Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know - MSN
CRISPR Therapeutics (NasdaqGM:CRSP) Sees 16% Stock Price Surge Over Last Month - simplywall.st
Crispr: Shares Very Undervalued, as Early-Stage Pipeline Makes Progress and Casgevy Launch Underway - Morningstar
CRSP Sees Significant Increase in Bullish Option Activity | CRSP Stock News - GuruFocus
Crispr Therapeutics call volume above normal and directionally bullish - TipRanks
CRISPR Therapeutics (CRSP) Up 11.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance
CRISPR Therapeutics AG (NASDAQ:CRSP) Stake Raised by Green Alpha Advisors LLC - MarketBeat
Can CRISPR Build on Casgevy's Success With Its In Vivo Pipeline? - sharewise
Promising Growth and Diversification Drive Buy Rating for Crispr Therapeutics AG - TipRanks
Can CRISPR Build On Casgevy's Success With Its In Vivo Pipeline? - Barchart.com
CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Sold by Voloridge Investment Management LLC - MarketBeat
Capital Market Strategies LLC Buys 9,652 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat
Q2 EPS Forecast for CRISPR Therapeutics Increased by Analyst - MarketBeat
1.02%
1.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):